Genesco Inc. (GCO) Income Statement

NYSE: GCORevenue, profits, margins and EPS over 10 years.

GCO FY2026 at a glance

Fiscal year ended January 31, 2026 · U.S. dollars
Revenue+4.8%
$2.44B
FY2026 · hover or tap a bar for each year
FY2017: $2.02B (−33.1%)FY2018: $2.13B (+5.3%)FY2019: $2.19B (+2.9%)FY2020: $2.20B (+0.4%)FY2021: $1.79B (−18.7%)FY2022: $2.42B (+35.6%)FY2023: $2.38B (−1.5%)FY2024: $2.32B (−2.5%)FY2025: $2.33B (+0.0%)FY2026: $2.44B (+4.8%)
FY2017FY2026
Gross profit+2.7%
$1.13B
FY2026 · hover or tap a bar for each year
FY2017: $975.9M (−32.4%)FY2018: $1.01B (+3.6%)FY2019: $1.05B (+3.5%)FY2020: $1.06B (+1.5%)FY2021: $804.5M (−24.3%)FY2022: $1.18B (+46.8%)FY2023: $1.14B (−3.8%)FY2024: $1.10B (−3.3%)FY2025: $1.10B (−0.2%)FY2026: $1.13B (+2.7%)
FY2017FY2026
Operating income+47.9%
$25.4M
FY2026 · hover or tap a bar for each year
FY2017: $107.8M (−28.7%)FY2018: $74.4M (−31.0%)FY2019: $81.8M (+10.0%)FY2020: $83.3M (+1.8%)FY2021: −$107.2M (−228.7%)FY2022: $147.5MFY2023: $94.1M (−36.2%)FY2024: $16.8M (−82.2%)FY2025: $17.2M (+2.3%)FY2026: $25.4M (+47.9%)
FY2017FY2026
Net income
$13.3M
FY2026 · hover or tap a bar for each year
FY2017: $97.4M (+3.0%)FY2018: −$111.8M (−214.8%)FY2019: −$51.9MFY2020: $61.4MFY2021: −$56.4M (−191.9%)FY2022: $114.8MFY2023: $71.9M (−37.4%)FY2024: −$16.8M (−123.4%)FY2025: −$18.9MFY2026: $13.3M
FY2017FY2026
EPS (diluted)+42.6%
$1.34
FY2026 · hover or tap a bar for each year
FY2017: $4.39 (+0.2%)FY2018: $3.13 (−28.7%)FY2019: $3.11 (−0.6%)FY2020: $4.90 (+57.6%)FY2021: −$1.27 (−125.9%)FY2022: $7.68FY2023: $5.74 (−25.3%)FY2024: $0.72 (−87.5%)FY2025: $0.94 (+30.6%)FY2026: $1.34 (+42.6%)
FY2017FY2026
Net profit margin+1.4 pts
0.5%
FY2026 · hover or tap a point for each year
FY2017: 4.8% (+1.7 pts)FY2018: −5.3% (−10.1 pts)FY2019: −2.4% (+2.9 pts)FY2020: 2.8% (+5.2 pts)FY2021: −3.2% (−6.0 pts)FY2022: 4.7% (+7.9 pts)FY2023: 3.0% (−1.7 pts)FY2024: −0.7% (−3.7 pts)FY2025: −0.8% (−0.1 pts)FY2026: 0.5% (+1.4 pts)
FY2017FY2026

GCO revenue and net income

RevenueNet incomeNet margin (right axis)

Where GCO's revenue goes

FY2026
Revenue
$2.44B100.0%
Cost of revenue
−$1.31B−53.7%
Gross profit
$1.13B46.3%
Sales, general & admin
−$1.10B−45.2%
Operating income
$25.4M1.0%
Interest & other expense
−$12.8M−0.5%
Net income
$13.3M0.5%

Each bar shows an amount and its share of revenue. GCO kept 0.5% of revenue as net income.

GCO profit margins

GrossOperatingNet

GCO growth rates

to FY2026
1 year3 years5 years10 years
Revenue+4.8%+0.7%+6.4%−2.1%
Gross profit+2.7%−0.3%+7.0%−2.4%
Operating income+47.9%−35.4%—−16.3%
Net income—−43.1%—−17.8%
EPS (diluted)+42.6%−38.4%—−11.2%

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

GCO quarterly EPS vs estimates

Reported EPSAnalyst estimate

Genesco beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: December 3, 2026 (estimate $0.94).

GCO income statement

Genesco Inc. annual income statement
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$2.44B$2.33B$2.32B$2.38B$2.42B$1.79B$2.20B$2.19B$2.13B$2.02B
Cost of revenue$1.31B$1.23B$1.23B$1.25B$1.24B$982.1M$1.13B$1.14B$1.12B$1.04B
Gross profit$1.13B$1.10B$1.10B$1.14B$1.18B$804.5M$1.06B$1.05B$1.01B$975.9M
Research & development———————$0$0$0
Sales, general & admin$1.10B$1.08B$1.09B$1.04B$1.03B$813.8M$966.4M$962.1M$1.32B$400.2M
Total operating expenses$1.10B$1.08B$1.08B$1.04B$1.03B$911.7M$979.8M$965.2M$937.0M$868.1M
Operating income$25.4M$17.2M$16.8M$94.1M$147.5M−$107.2M$83.3M$81.8M$74.4M$107.8M
Interest income$700,000$700,000$400,000$2.9M$2.4M$5.1M$2.1M$774,000$8,000$47,000
Interest expense$4.8M$5.0M$8.2M$3.2M$2.4M$5.1M$3.3M$4.1M$5.4M$5.3M
Income before taxes$12.6M$9.3M−$21.8M$90.1M$153.0M−$111.7M$82.4M$78.3M$69.0M$112.8M
Income taxes−$685,000$28.8M$1.9M$17.8M$38.0M−$55.6M$20.7M$27.0M$32.3M$39.9M
Net income$13.3M−$18.9M−$16.8M$71.9M$114.8M−$56.4M$61.4M−$51.9M−$111.8M$97.4M
EBITDA$70.7M$66.7M$35.8M$136.1M$198.4M−$60.1M$133.3M$158.5M$152.7M$193.8M
EPS (diluted)$1.34$0.94$0.72$5.74$7.68−$1.27$4.90$3.11$3.13$4.39
Gross margin46.3%47.2%47.3%47.6%48.8%45.0%48.4%47.8%47.5%48.3%
Operating margin1.0%0.7%0.7%3.9%6.1%−6.0%3.8%3.7%3.5%5.3%
Net margin0.5%−0.8%−0.7%3.0%4.7%−3.2%2.8%−2.4%−5.3%4.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in GCO's financial statements (latest annual report filed March 25, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

GCO financial results

In fiscal year 2026 (ended January 31, 2026), Genesco reported revenue of $2.4 billion, up 4.8% from the year before. It had net income of $13.3 million, a net profit margin of 0.5%. Diluted earnings per share came to $1.34. Over five years revenue grew at an average rate of 6.4% a year.

See the GCO stock overview for the latest quote and news, or the GCO chart for price history and technical indicators.

GCO income statement FAQ

What is Genesco's annual revenue?

Genesco reported total revenue of $2.4 billion for fiscal year 2026, which ended on January 31, 2026. That was up 4.8% from $2.3 billion the previous year.

Is Genesco profitable?

Yes. Genesco reported net income of $13.3 million in fiscal 2026, a net profit margin of 0.5%; its operating margin was 1.0%.

What is Genesco's gross margin?

Genesco's gross margin was 46.3% in fiscal 2026: for every $100 of revenue, Genesco kept $46 after the direct cost of its products and services.

How fast is Genesco growing?

Revenue grew 6.4% a year on average over the last five fiscal years, from $1.8 billion to $2.4 billion.

What are Genesco's earnings per share?

Genesco earned $1.34 per diluted share in fiscal 2026, compared with $0.94 a year earlier.

When will Genesco report its next earnings?

Genesco is expected to report results for the quarter ending October 31, 2026 on December 3, 2026 before the market opens.

When does Genesco's fiscal year end?

Genesco's fiscal year ends in January. The latest annual report covers the year ended January 31, 2026 and was filed on March 25, 2026.

Apparel Retail income statements